A team of researchers from UMBC is developing a new, low-cost anti-malarial drug to help tackle a disease that causes over 200 million infections and 400,000 deaths annually, according to the World Health Organization (WHO).
Post Info
| posted | July 23, 2018 |
|---|---|
| sponsor | Corporate and Foundation Relations |
| tags | cbeecfrcoeitscience-and-technology |
| share |
|
Recent Posts
-
Posted over 6 years ago
-
Posted almost 7 years ago
-
Posted over 7 years ago
-
Posted over 7 years ago
All events, groups, organizations, and centers are open for full participation by all individuals regardless of race, color, religion, sex, national origin, or any other protected category under applicable federal law, state law, and the University's nondiscrimination policy.
myUMBC is a UMBC limited public community forum for information sharing and dialogue. As a public institution, UMBC generally may not limit a community member's right to free speech on this forum. UMBC does not endorse the views expressed or information presented here, unless specifically stated in an official UMBC post. Learn more...
#6066 - DEV - development - dev - general-public